2008
DOI: 10.1007/s00383-008-2264-z
|View full text |Cite
|
Sign up to set email alerts
|

Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?

Abstract: In contrast to L1, which was found to predict favorable outcome, NCAM is universally expressed in neuroblastoma. Therefore NCAM represents a marker for neuroblastomas irrespectively of their stages whereas L1 as an indicator for developing neuronal cells seems to identify more mature stages of this tumor. The high grade of NCAM expression might present a prerequisite for establishment of antibody-based therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 17 publications
0
20
0
Order By: Relevance
“…As shown in Figure 1AB, FISH analysis performed on GD2 positive cell preparations from two patients with MYCN amplification showed presence of MYCN amplification. Cytospins of GD2 positive cell preparations were enriched in mononuclear NB cells expressing the NB-specific markers GD2, CD56 [15] and NB84 [16] (Figure 1C, D and E, respectively). Cytofluorimetric analysis showed that less than 5% of the cells recovered by GD2-positive immunomagnetic bead manipulation expressed CD45, whereas more than 95% expressed the B7H3 antigen (Figure 1F and G, respectively).…”
Section: Resultsmentioning
confidence: 98%
“…As shown in Figure 1AB, FISH analysis performed on GD2 positive cell preparations from two patients with MYCN amplification showed presence of MYCN amplification. Cytospins of GD2 positive cell preparations were enriched in mononuclear NB cells expressing the NB-specific markers GD2, CD56 [15] and NB84 [16] (Figure 1C, D and E, respectively). Cytofluorimetric analysis showed that less than 5% of the cells recovered by GD2-positive immunomagnetic bead manipulation expressed CD45, whereas more than 95% expressed the B7H3 antigen (Figure 1F and G, respectively).…”
Section: Resultsmentioning
confidence: 98%
“…Most Oct-4 + and Oct-4 − cells expressed VEGF-R2 (Supplementary information, Figure S1, [13][14][15] [8], and the neuroblastic markers GD2 (Supplementary information, Figure S1, 9-11), CD56 (Supplementary information, Figure S1, [17][18][19] [8,49,50] and NB84 ( Figure 2A). All isotypic controls used for immunofluorescence tested negative ( Figure 2B Figure S1, 4,8,12,16,20).…”
Section: Identification and Immunophenotypic Characterization Of Oct-mentioning
confidence: 99%
“…At variance with TEC, bulk tumor cells did not express PSMA, vWF, CD105, HLA-class I or HLA-G ( Figure 6A). Most TECs were found to express the NB-associated markers GD2 [49] NB84 [41], and CD56 [50] ( Figure 6B, 6-8), which were shared by most tumor cells ( Figure 6A). …”
Section: Kinetics Of Human and Mouse Em Formation In Orthotopic Tumormentioning
confidence: 99%
“…In contrast to that in human glioblastomas, an association of L1 positivity with greater event-free and overall survival has been observed in patients with neuroblastoma. L1 negativity is independently prognostic of event-free and overall survival, and predicts a good outcome in children with neuroblastoma (15,16). Thus, L1 may function differently in the two tumor types.…”
Section: Introductionmentioning
confidence: 99%